Evidence map›Paper›PMID 34552867›Full record

ReviewFrontiers in oncology2021

Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers.

Chiara Tommasi, Benedetta Pellegrino, Daniela Boggiani, Angelica Sikokis, Maria Michiara, Vera Uliana, Beatrice Bortesi, Francesco Bonatti, Paola Mozzoni, Silvana Pinelli and 6 more

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chiara TommasiMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Benedetta PellegrinoMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Daniela BoggianiMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Angelica SikokisMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Maria MichiaraMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Vera UlianaMedical Genetics Unit, University Hospital of Parma, Parma, Italy.
Beatrice BortesiMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Francesco BonattiMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Paola MozzoniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Silvana PinelliDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Anna SquadrilliMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Maria Vittoria VianiDental School, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Diana CassiUnit of Dentistry and Oral-Maxillo-Facial Surgery, Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Giuseppe MagliettaGOIRC (Gruppo Oncologico Italiano di Ricerca Clinica), Parma, Italy.
Marco MeletiDental School, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Antonino MusolinoMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women with pathogenic germline mutations in

Indexed as

BRCA1/2 mutationsbreast cancerbreast cancer riskmiRNAsnutriepigenomics

Identifiers

PMID34552867
PMCPMC8450578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.